Biopsy Techniques

Biopsy Basics - The First Cut

• Purpose: Diagnose (benign/malignant), grade, stage; guide treatment. Crucial before definitive surgery.
• Indications: Suspicious lesion on imaging (X-ray, MRI).
• Core Principles:
  • Longitudinal incision, planned for future resection.
  • Prevent tumor seeding; meticulous hemostasis.
  • Biopsy tract must be resectable with specimen.
  • Adequate, representative tissue.
  • Avoid neurovascular structures, joint spaces.
  • Pathologist coordination: fresh tissue (special studies), formalin (routine).
  • ⚠️ Poor technique compromises limb salvage.

⭐ Biopsy tract is considered contaminated; must be excised en bloc with the tumor during definitive surgery.

Needle vs. Knife - The Great Debate

• Needle Biopsy (Percutaneous):

  • Core Needle Biopsy (CNB) preferred over FNAC for sarcomas (provides architecture).
  • Pros: Minimally invasive, local anesthesia, ↓cost, ↓morbidity, outpatient. Often image-guided (USG/CT).
  • Cons: ↑Sampling error risk (heterogeneous tumors). Coaxial technique ↓seeding.
  • Accuracy: CNB ~90-95% with experience.

• Open Biopsy (Surgical):

  • Incisional (representative sample) vs. Excisional (entire lesion - rare for primary bone malignancy).
  • Pros: Gold standard. Ample tissue for definitive diagnosis, grading, molecular studies.
  • Cons: Invasive, general/regional anesthesia, ↑cost, ↑hospital stay, ↑complications (infection, hematoma, pathological fracture).
  • Crucial: Longitudinal incision, planned for en bloc resection with tumor.

⭐ Biopsy tract MUST be resectable en bloc with tumor at definitive surgery to prevent recurrence.

The Perfect Path - Biopsy Blueprint

• Pre-Biopsy Protocol: Foundation for Success
  • MDT consensus; review all imaging (X-ray, MRI ± CT).
  • Biopsy after full staging investigations.
  • Definitive surgeon plans/performs biopsy.
  • Longitudinal incision: tract designed for en-bloc excision.
  • Avoid: Neurovascular bundles, joint spaces, reactive zones.
• Technique & Specimen Logistics:
  • Obtain adequate, representative tissue (avoid necrosis).
  • Meticulous hemostasis to prevent hematoma.
  • Gentle handling; label specimen accurately.
  • Samples: Histopathology (formalin), Microbiology (saline), Cytogenetics (RPMI/saline), Fresh for research.
  • Frozen section: confirms diagnostic yield.
• Closure & Considerations:
  • Secure hemostasis.
  • Layered closure; drain (if used) exits in line with incision.

> ⭐ A poorly planned biopsy can compromise limb salvage options or even curative intent.

Oops & Uh-Ohs - Complication Control

• Hemorrhage/Hematoma:
  • Prevention: Avoid large vessels, careful technique, pressure.
  • Management: Pressure; rarely embolization.
• Infection:
  • Prevention: Strict asepsis; prophylactic antibiotics (deep biopsies).
  • Management: Antibiotics, debridement.
• Tumor Seeding/Contamination: ⚠️
  • Prevention: Longitudinal incision, tract excision with surgery, avoid new compartments.

  ⭐ Biopsy tract: orient longitudinally, plan for en-bloc resection with tumor during definitive surgery to prevent local recurrence.

• Pathological Fracture:
  • Prevention: Gentle handling (lytic lesions); core needle for weak bone.
  • Management: Stabilization.
• Neurovascular Injury:
  • Prevention: Image guidance, anatomy knowledge.
  • Management: Repair if needed.
• Non-Diagnostic Sample:
  • Prevention: Multiple cores, viable tissue, intra-op check.
  • Management: Repeat biopsy_

High‑Yield Points - ⚡ Biggest Takeaways

• Biopsy tract must be planned for en-bloc excision with definitive surgery.
• Core needle (Tru-Cut) biopsy is standard initial diagnosis for most suspected sarcomas.
• Open biopsy offers most tissue but ↑ risk of contamination and hematoma.
• FNAC is limited for sarcoma diagnosis; better for metastatic carcinoma or lymphoma.
• Longitudinal incisions are preferred; transverse incisions compromise limb salvage.
• Frozen section during open biopsy confirms diagnostic tissue, not definitive diagnosis.
• Biopsy after complete imaging (X-ray, MRI) to avoid altering findings.